Registered number: 11883125 | ||||||||
FOR THE YEAR ENDED 31 MARCH 2024 | ||||||||
Prepared By: | ||||||||
Hope Jones | ||||||||
Chartered Accountants | ||||||||
Suite114, Lymington Town Hall | ||||||||
Avenue Road | ||||||||
Lymington | ||||||||
Hants | ||||||||
SO41 9ZG |
Healthcare International Research Limited | ||||||||
ACCOUNTS | ||||||||
FOR THE YEAR ENDED 31 MARCH 2024 | ||||||||
DIRECTORS | ||||||||
REGISTERED OFFICE | ||||||||
Dorset | ||||||||
COMPANY DETAILS | ||||||||
Private company limited by shares registered in England and Wales, registered number 11883125 | ||||||||
ACCOUNTANTS | ||||||||
Hope Jones | ||||||||
Chartered Accountants | ||||||||
Suite114, Lymington Town Hall | ||||||||
Avenue Road | ||||||||
Lymington | ||||||||
Hants | ||||||||
SO41 9ZG |
Healthcare International Research Limited | ||||||||
ACCOUNTS | ||||||||
FOR THEYEARENDED31 MARCH 2024 | ||||||||
CONTENTS | ||||||||
Page | ||||||||
Statement of Financial Position | 3 | |||||||
Notes to the Accounts | 4 - 6 | |||||||
Healthcare International Research Limited | ||||||||
STATEMENT OF FINANCIAL POSITION AT | ||||||||||
2024 | 2023 | |||||||||
Notes | £ | £ | ||||||||
FIXED ASSETS | ||||||||||
Tangible assets | 3 | |||||||||
Investment assets | 4 | |||||||||
CURRENT ASSETS | ||||||||||
Stock | ||||||||||
Debtors | 5 | |||||||||
Cash at bank and in hand | ||||||||||
276,655 | 107,110 | |||||||||
CREDITORS: Amounts falling due within one year | 6 | |||||||||
NET CURRENT ASSETS | 26,916 | |||||||||
TOTAL ASSETS LESS CURRENT LIABILITIES | ||||||||||
CREDITORS: Amounts falling due after more than one year | 7 | 7,528 | 15,660 | |||||||
NET ASSETS | ||||||||||
CAPITAL AND RESERVES | ||||||||||
Called up share capital | ||||||||||
Share premium account | ||||||||||
Profit and loss account | (1,548,028) | (866,044) | ||||||||
SHAREHOLDERS' FUNDS | ||||||||||
Approved by the board on | ||||||||||
............................. | ||||||||||
Director | ||||||||||
Healthcare International Research Limited | ||||||||
NOTES TO THE ACCOUNTS | ||||||||||
FOR THE YEAR ENDED 31 MARCH 2024 | ||||||||||
1. ACCOUNTING POLICIES |
1a. Basis Of Accounting FRS 1021 a | ||||||||
The accounts have been prepared under the historical cost convention. | ||||||||
The accounts have been prepared in accordance with FRS102 section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. The company has taken advantage of the exemption from the requirement to prepare consolidated financial statements as set out in section 399 (2A) of the Companies Act 2006. |
1b. Depreciation | ||||||||
Website | straight line 25% | |||||||
Fixtures, Fittings and Furniture | reducing balance 25% | |||||||
Equipment | straight line 25% | |||||||
Motor Bike | reducing balance 10% |
1c. Stocks | ||||||||
Stocks are stated at the lower of cost and estimated selling price less costs to sell (net realisable value). | ||||||||
1d. Pension Costs | ||||||||
The company operates a defined contribution pension scheme. The pension charge represents the amounts payable by the company to the fund in respect of the year. |
1e. Foreign Currency | ||||||||
Transactions in currencies, other than the functional currency of the company, are recorded at the rate of the exchange on the date the transaction occurred. Monetary items denominated in other currencies are translated at the rate prevailing at the end of the reporting period. All differences are taken to the profit and loss account. Non-monetary items that are measured at the historic cost in a foreign currency are not retranslated. |
1f. Investment Assets | ||||||||
Fixed asset investments are shown at cost less amounts written off. | ||||||||
Provisions are made for permanent fluctuations in value. |
2. EMPLOYEES | ||||||
2024 | 2023 | |||||
No. | No. | |||||
Average number of employees | 2 | |||||
Healthcare International Research Limited | ||||||||
3. TANGIBLE FIXED ASSETS | ||||||||||
Fixtures, Fittings | ||||||||||
Website | and Furniture | Equipment | Motor Bike | Total | ||||||
£ | £ | £ | £ | £ | ||||||
Cost | ||||||||||
At 1 April 2023 | 7,605 | 6,037 | 11,660 | - | 25,302 | |||||
Additions | - | 5,776 | 11,141 | 10,083 | 27,000 | |||||
At 31 March 2024 | 7,605 | 11,813 | 22,801 | 10,083 | 52,302 | |||||
Depreciation | ||||||||||
At 1 April 2023 | 3,588 | 1,509 | 4,906 | - | 10,003 | |||||
For the year | 1,339 | 2,576 | 5,700 | 1,008 | 10,623 | |||||
At 31 March 2024 | 4,927 | 4,085 | 10,606 | 1,008 | 20,626 | |||||
Net Book Amounts | ||||||||||
At 31 March 2024 | 31,676 | |||||||||
At 31 March 2023 | 15,299 | |||||||||
4. INVESTMENT ASSETS | |||||||||
Shares in group companies | |||||||||
and participating interests | Total | ||||||||
£ | £ | ||||||||
Cost | |||||||||
At 1 April 2023 | 5,109 | 5,109 | |||||||
Additions | 100 | 100 | |||||||
At 31 March 2024 | 5,209 | 5,209 | |||||||
Amortisation | |||||||||
At 1 April 2023 | 5,108 | 5,108 | |||||||
At 31 March 2024 | 5,108 | 5,108 | |||||||
Net Book Amounts | |||||||||
At 31 March 2024 | 101 | 101 | |||||||
At 31 March 2023 | 1 | 1 | |||||||
5. DEBTORS | 2024 | 2023 | ||||||
£ | £ | |||||||
Amounts falling due within one year | ||||||||
Trade debtors | 6,305 | 25,311 | ||||||
VAT | 590 | 13,247 | ||||||
Other debtors | 18,419 | 7,850 | ||||||
Amounts due from group companies (net of provision for non-recovery) | 76,078 | 28,679 | ||||||
Prepayments | 23,531 | 3,732 | ||||||
Directors current account | - | 9,744 | ||||||
124,923 | 88,563 | |||||||
Healthcare International Research Limited | ||||||||
6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR | ||||||||
2024 | 2023 | |||||||
£ | £ | |||||||
Taxation and social security | 4,197 | 4,746 | ||||||
Directors current account | 165 | - | ||||||
Bank Loan | 4,517 | - | ||||||
Loans (note 9) | 130,700 | 59,666 | ||||||
Trade creditors | 6,247 | 8,564 | ||||||
Other creditors | 127 | 89 | ||||||
Accruals | 10,379 | 7,129 | ||||||
156,332 | 80,194 | |||||||
7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR | ||||||||
2024 | 2023 | |||||||
£ | £ | |||||||
Bank loan | 7,528 | 15,660 | ||||||
7,528 | 15,660 | |||||||
8. LOAN TO DIRECTOR | ||||||||
At the beginning of the year, director, F A Darver, owed the company £9,744 on director's current account, interest-free and repayable on demand. This was repaid during the year. | ||||||||
9. POST BALANCE SHEET EVENT | ||||||||
Loans (note 6) include £128,964 (2023 £59,000) received from investors which after the end of the accounting year were used to acquire ordinary shares in the company. | ||||||||